{"id":1044,"date":"2026-07-03T09:01:15","date_gmt":"2026-07-03T09:01:15","guid":{"rendered":"https:\/\/isbm-blow-molding.com\/?p=1044"},"modified":"2026-07-03T09:01:15","modified_gmt":"2026-07-03T09:01:15","slug":"hdpe-eye-drop-bottle-ibm-korean-production-guide","status":"publish","type":"post","link":"https:\/\/isbm-blow-molding.com\/fr\/hdpe-eye-drop-bottle-ibm-korean-production-guide\/","title":{"rendered":"Flacon de gouttes oculaires en PEHD IBM : Guide de production cor\u00e9en"},"content":{"rendered":"<header style=\"position: relative; min-height: min(560px,84vh); display: flex; align-items: center; padding: clamp(40px,6vw,80px) clamp(18px,5vw,56px); box-sizing: border-box; width: 100%; background: #03111e; background-image: linear-gradient(150deg,rgba(2,8,18,0.97) 0%,rgba(4,18,38,0.94) 55%,rgba(3,105,161,0.28) 100%),url('https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/07\/Injection-Blow-Molding-Machine-ZQ60.webp'); background-size: cover; background-position: center;\">\n<div style=\"max-width: 680px;\"><span style=\"display: inline-block; font-size: 10px; font-weight: bold; letter-spacing: 2.5px; text-transform: uppercase; color: #7dd3fc; border: 1px solid rgba(125,211,252,0.32); padding: 4px 12px; border-radius: 3px; margin-bottom: 18px;\">Ophtalmique IBM \u00b7 Flacon de gouttes oculaires \u00b7 KFDA cor\u00e9en \u00b7 Korea Ever-Power<\/span><\/p>\n<h1 style=\"font-size: clamp(24px,4.2vw,40px); font-weight: 900; color: #fff; line-height: 1.18; margin: 0 0 20px; letter-spacing: -0.5px;\">Flacon de gouttes oculaires en PEHD IBM\u00a0:<br \/>\nGuide de production cor\u00e9en<\/h1>\n<p style=\"font-size: clamp(14px,1.9vw,17px); color: #bae6fd; line-height: 1.7; margin: 0 0 28px; max-width: 560px;\">Les contenants ophtalmiques cor\u00e9ens en PEHD de 10 ml sont le format pharmaceutique IBM le plus volumineux en Cor\u00e9e et l'un des plus exigeants sur le plan technique : pr\u00e9cision d'engagement du bouchon compte-gouttes \u00e0 \u00b10,05 mm, transparence du niveau de remplissage \u00e0 0,30\u20130,40 mm de paroi du corps, conformit\u00e9 aux exigences de la KFDA en mati\u00e8re de particules ophtalmiques et exigences de volume annuel de plusieurs centaines de millions d'unit\u00e9s qui placent les machines ZQ110 et ZQ135 au centre de l'\u00e9conomie de la production d'emballages ophtalmiques cor\u00e9ens.<\/p>\n<div style=\"display: flex; flex-wrap: wrap; gap: 8px;\"><span style=\"background: rgba(255,255,255,0.08); border: 1px solid rgba(255,255,255,0.18); color: #bae6fd; font-size: 11.5px; font-weight: 600; padding: 5px 14px; border-radius: 20px;\">\u00c9conomie du nombre de caries de 10 ml<\/span><br \/>\n<span style=\"background: rgba(255,255,255,0.08); border: 1px solid rgba(255,255,255,0.18); color: #bae6fd; font-size: 11.5px; font-weight: 600; padding: 5px 14px; border-radius: 20px;\">Pr\u00e9cision du col du bouchon de la pipette<\/span><br \/>\n<span style=\"background: rgba(255,255,255,0.08); border: 1px solid rgba(255,255,255,0.18); color: #bae6fd; font-size: 11.5px; font-weight: 600; padding: 5px 14px; border-radius: 20px;\">Qualification ophtalmique KFDA<\/span><\/div>\n<p style=\"font-size: 11px; color: #38bdf8; margin: 22px 0 0;\">Bureau d'ing\u00e9nierie d'Ever-Power Cor\u00e9e \u00b7 Ansan-si \u00b7 Juillet 2026<\/p>\n<\/div>\n<\/header>\n<p>&nbsp;<\/p>\n<p><!-- KPI BAR --><\/p>\n<div style=\"background: #f0f9ff; border: 1px solid #bae6fd; border-radius: 8px; padding: 20px 24px; margin: 44px 0 0;\">\n<p style=\"font-size: 10.5px; font-weight: 800; letter-spacing: 2px; text-transform: uppercase; color: #0369a1; margin: 0 0 14px;\">Donn\u00e9es de r\u00e9f\u00e9rence pour l'IBM ophtalmique cor\u00e9enne<\/p>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit,minmax(min(100%,150px),1fr)); gap: 12px;\">\n<div style=\"background: #fff; border-radius: 6px; padding: 14px; border-top: 3px solid #0369a1; text-align: center;\">\n<p style=\"font-size: 22px; font-weight: 900; color: #0369a1; margin: 0 0 4px;\">10 ml<\/p>\n<p style=\"font-size: 12px; color: #374151; margin: 0; line-height: 1.4;\">Contenant ophtalmique standard cor\u00e9en \u2014 le format IBM, le plus demand\u00e9 annuellement<\/p>\n<\/div>\n<div style=\"background: #fff; border-radius: 6px; padding: 14px; border-top: 3px solid #0284c7; text-align: center;\">\n<p style=\"font-size: 22px; font-weight: 900; color: #0369a1; margin: 0 0 4px;\">Plus de 500 millions<\/p>\n<p style=\"font-size: 12px; color: #374151; margin: 0; line-height: 1.4;\">Demande annuelle estim\u00e9e de produits ophtalmiques en Cor\u00e9e (lentilles de contact, s\u00e9cheresse oculaire, ordonnances).<\/p>\n<\/div>\n<div style=\"background: #fff; border-radius: 6px; padding: 14px; border-top: 3px solid #0ea5e9; text-align: center;\">\n<p style=\"font-size: 22px; font-weight: 900; color: #0369a1; margin: 0 0 4px;\">\u00b10,05 mm<\/p>\n<p style=\"font-size: 12px; color: #374151; margin: 0; line-height: 1.4;\">Tol\u00e9rance du diam\u00e8tre ext\u00e9rieur du col IBM \u2014 l'engagement du bouchon compte-gouttes n\u00e9cessite une fen\u00eatre de \u00b10,06 mm<\/p>\n<\/div>\n<div style=\"background: #fff; border-radius: 6px; padding: 14px; border-top: 3px solid #38bdf8; text-align: center;\">\n<p style=\"font-size: 22px; font-weight: 900; color: #0369a1; margin: 0 0 4px;\">~23\u00a0800\/h<\/p>\n<p style=\"font-size: 12px; color: #374151; margin: 0; line-height: 1.4;\">ZQ135 \u00e0 30 cavit\u00e9s \u2014 production IBM ophtalmique monomachine cor\u00e9enne la plus \u00e9lev\u00e9e<\/p>\n<\/div>\n<\/div>\n<\/div>\n<p><!-- TOC --><\/p>\n<nav style=\"margin: 32px 0 0; background: #f9fafb; border: 1px solid #e5e7eb; border-radius: 8px; padding: 20px 22px;\">\n<p style=\"font-size: 10.5px; font-weight: bold; text-transform: uppercase; letter-spacing: 1.5px; color: #374151; margin: 0 0 12px;\">Contenu<\/p>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit,minmax(min(100%,260px),1fr)); gap: 4px 20px;\"><a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#s1\">1. Korean Ophthalmic Market and IBM&#8217;s Role<\/a><br \/>\n<a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#s2\">2. Sp\u00e9cifications du r\u00e9cipient ophtalmique en PEHD de 10 ml<\/a><br \/>\n<a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#s3\">3. Pr\u00e9cision du col IBM pour l'engagement du bouchon compte-gouttes<\/a><br \/>\n<a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#s4\">4. Qualit\u00e9 et traitement du PEHD pour l'IBM ophtalmique<\/a><br \/>\n<a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#s5\">5. Qualification ophtalmologique KFDA cor\u00e9enne<\/a><br \/>\n<a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#s6\">6. Installation d'une salle blanche IBM pour la production ophtalmique<\/a><br \/>\n<a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#s7\">7. Analyse \u00e9conomique du nombre de caries pour l'ophtalmologie cor\u00e9enne (IBM)<\/a><br \/>\n<a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#s8\">8. S\u00e9lection de la s\u00e9rie ZQ pour la production ophtalmique cor\u00e9enne<\/a><br \/>\n<a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#faq\">FAQ<\/a><\/div>\n<\/nav>\n<p><!-- S1 --><\/p>\n<section id=\"s1\" style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #0369a1;\">\n<h2 style=\"font-size: clamp(18px,2.6vw,24px); font-weight: 800; color: #0369a1; margin: 0 0 18px;\">1. Korean Ophthalmic Market and IBM&#8217;s Role<\/h2>\n<figure style=\"margin: 0 0 22px;\"><img decoding=\"async\" style=\"width: 100%; height: auto; border-radius: 8px; display: block;\" title=\"Korean HDPE Ophthalmic Containers \u2014 IBM Production\" src=\"https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/07\/Pharmaceutical-Bottles.webp\" alt=\"Korean HDPE ophthalmic eye drop bottles \u2014 10ml injection blow molded pharmaceutical container with dropper cap 13\/415 neck finish, 0.35mm body wall translucency for fill-level inspection, produced by Korea Ever-Power ZQ80 ZQ110 at 20-24 cavity Korean pharmaceutical ophthalmic IBM production for Korean KFDA ophthalmic container qualification\" \/><figcaption style=\"font-size: 12px; color: #6b7280; margin-top: 8px; text-align: center;\">Flacons ophtalmiques cor\u00e9ens de 10 ml en PEHD, fabriqu\u00e9s par moulage par injection-soufflage. Le col du compte-gouttes (13\/415) pr\u00e9sente une tol\u00e9rance de \u00b10,05 mm de diam\u00e8tre ext\u00e9rieur pour la fixation du bouchon. L'\u00e9paisseur de la paroi (0,30\u20130,40 mm) permet un contr\u00f4le translucide du niveau de remplissage. Le fond moul\u00e9 par injection ne pr\u00e9sente aucune trace de joint ni de point d'injection visible de l'ext\u00e9rieur. Avec 20 \u00e0 30 cavit\u00e9s par cycle, le proc\u00e9d\u00e9 IBM est le seul proc\u00e9d\u00e9 de moulage par soufflage permettant de produire simultan\u00e9ment des volumes ophtalmiques cor\u00e9ens r\u00e9pondant aux exigences de qualit\u00e9 pharmaceutique et \u00e0 un co\u00fbt comp\u00e9titif.<\/figcaption><\/figure>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">Korea&#8217;s ophthalmic pharmaceutical market is among the largest and fastest-growing in East Asia. Three structural factors drive Korean ophthalmic container demand above what Korea&#8217;s population size alone would suggest: the world&#8217;s highest rate of contact lens wear per capita (approximately 42% of Korean adults aged 20\u201340 wear contact lenses, generating daily artificial tear and contact lens solution demand), the exceptionally high Korean screen time (Korean workers average 9.4 hours per day of screen exposure, driving rapidly growing dry-eye disease prevalence), and Korea&#8217;s nationally covered ophthalmic prescription reimbursement system (Korean National Health Insurance covers most ophthalmic prescription medications, lowering the price barrier to ophthalmic pharmaceutical use). These three factors together produce an estimated 500+ million annual ophthalmic container demand in Korea, split between prescription ophthalmic (antibiotics, anti-inflammatory, antiglaucoma), OTC artificial tears, and contact lens care products \u2014 all requiring 10 ml HDPE IBM containers.<\/p>\n<p style=\"font-size: 16px; margin-bottom: 0;\">Le proc\u00e9d\u00e9 IBM est la norme cor\u00e9enne pour la fabrication de flacons ophtalmiques, car le format ophtalmique de 10 ml b\u00e9n\u00e9ficie simultan\u00e9ment de tous ses avantages techniques\u00a0: col moul\u00e9 par injection \u00e0 \u00b10,05 mm (l\u2019engagement du bouchon compte-gouttes requiert \u00b10,06 mm), absence de bavures (conformit\u00e9 aux normes KFDA relatives aux particules ophtalmiques), production multicavit\u00e9s jusqu\u2019\u00e0 30 cavit\u00e9s (rentabilit\u00e9 pour une demande annuelle sup\u00e9rieure \u00e0 500 millions d\u2019unit\u00e9s) et paroi du corps en PEHD translucide de 0,30 \u00e0 0,40 mm (contr\u00f4le du niveau de remplissage sans exigence de transparence). Aucun autre proc\u00e9d\u00e9 de soufflage n\u2019offre ces quatre avantages pour le format 10 ml. Le contexte plus large de l\u2019utilisation d\u2019IBM dans la production pharmaceutique cor\u00e9enne est abord\u00e9 dans [r\u00e9f\u00e9rence manquante]. <a style=\"color: #0369a1; font-weight: 600; text-decoration: none;\" href=\"https:\/\/isbm-blow-molding.com\/fr\/pharmaceutical-injection-blow-molding\/\">Guide pharmaceutique IBM<\/a>; cet article se concentre sp\u00e9cifiquement sur la production de r\u00e9cipients ophtalmiques en PEHD de 10 ml.<\/p>\n<\/section>\n<p><!-- S2 --><\/p>\n<section id=\"s2\" style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #e5e7eb;\">\n<h2 style=\"font-size: clamp(18px,2.6vw,24px); font-weight: 800; color: #0369a1; margin: 0 0 18px;\">2. Sp\u00e9cifications du r\u00e9cipient ophtalmique en PEHD de 10 ml<\/h2>\n<figure style=\"margin: 0 0 22px;\"><img decoding=\"async\" style=\"width: 100%; height: auto; border-radius: 8px; display: block;\" title=\"10ml Ophthalmic IBM Process \u2014 Korea Ever-Power\" src=\"https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/07\/IBM-operating-principle.webp\" alt=\"IBM 3-station process for 10ml ophthalmic HDPE container \u2014 Station 1 injection at 800-1350KN of 10ml preform with 13\/415 dropper neck insert, Station 2 blow moulding to 25mm body diameter 45mm height, Station 3 stripping \u2014 20-30 cavity simultaneous production on Korea Ever-Power ZQ80 ZQ110 ZQ135 for Korean ophthalmic pharmaceutical HDPE IBM production\" \/><figcaption style=\"font-size: 12px; color: #6b7280; margin-top: 8px; text-align: center;\">Le proc\u00e9d\u00e9 IBM \u00e0 3 stations est appliqu\u00e9 \u00e0 la production de flacons ophtalmiques de 10 ml. Les trois stations fonctionnent simultan\u00e9ment\u00a0: la station 1 moule par injection 20 \u00e0 30 pr\u00e9formes ophtalmiques, la station 2 souffle 20 \u00e0 30 flacons du cycle pr\u00e9c\u00e9dent et la station 3 \u00e9jecte 20 \u00e0 30 flacons finis du cycle d'avant. Cette ex\u00e9cution simultan\u00e9e permet \u00e0 IBM, avec 30 cavit\u00e9s, d'atteindre une production d'environ 23\u00a0800 flacons ophtalmiques par heure, malgr\u00e9 un temps d'ex\u00e9cution de seulement quelques secondes par station.<\/figcaption><\/figure>\n<p style=\"font-size: 16px; margin-bottom: 20px;\">Les flacons ophtalmiques cor\u00e9ens en PEHD de 10 ml suivent des sp\u00e9cifications dimensionnelles remarquablement standardis\u00e9es parmi les marques pharmaceutiques cor\u00e9ennes \u2014 une standardisation due \u00e0 la compatibilit\u00e9 avec les syst\u00e8mes de bouchons compte-gouttes fournis par les fabricants cor\u00e9ens de bouchons compte-gouttes et aux sp\u00e9cifications des lignes de remplissage pharmaceutiques cor\u00e9ennes optimis\u00e9es pour les dimensions du format ophtalmique standard de 10 ml.<\/p>\n<div style=\"overflow-x: auto; margin: 0 0 22px;\">\n<table style=\"width: 100%; border-collapse: collapse; font-size: 13.5px; min-width: 460px;\">\n<thead>\n<tr style=\"background: #0369a1;\">\n<th style=\"color: #fff; padding: 10px 12px; text-align: left; font-weight: bold;\">Dimension<\/th>\n<th style=\"color: #fff; padding: 10px 12px; text-align: center; font-weight: bold;\">Sp\u00e9cification<\/th>\n<th style=\"color: #fff; padding: 10px 12px; text-align: left; font-weight: bold;\">Base fonctionnelle \/ des exigences<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">Finition du manche<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; font-weight: bold;\">13\/415 GPI<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd;\">Interface standard cor\u00e9enne pour bouchon compte-gouttes ophtalmique \u2014 compatible avec les fournisseurs cor\u00e9ens de bouchons compte-gouttes et de bouchons ophtalmiques CRC<\/td>\n<\/tr>\n<tr style=\"background: #f0f9ff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">Tol\u00e9rance du diam\u00e8tre ext\u00e9rieur du col<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; font-weight: bold; color: #0369a1;\">13,00 mm \u00b10,05 mm<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd;\">Fen\u00eatre de tol\u00e9rance d'enclenchement du bouchon compte-gouttes \u2014 IBM natif, \u00b10,05 mm sur toutes les cavit\u00e9s<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">Diam\u00e8tre int\u00e9rieur de l'al\u00e9sage<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; font-weight: bold;\">9,0 mm \u00b10,04 mm<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd;\">Diam\u00e8tre ext\u00e9rieur de l'insert de la tige de distribution \u2014 d\u00e9fini par le diam\u00e8tre ext\u00e9rieur de la tige centrale dans le moule d'injection IBM<\/td>\n<\/tr>\n<tr style=\"background: #f0f9ff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">Hauteur du conteneur<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; font-weight: bold;\">42\u201352 mm<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd;\">Compatibilit\u00e9 des pinces de remplissage cor\u00e9ennes et dimensions des plateaux de distribution des pharmacies cor\u00e9ennes<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">Diam\u00e8tre maximal du corps<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; font-weight: bold;\">22\u201328 mm<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd;\">Espacement maximal des rang\u00e9es de plateaux de distribution unidoses en pharmacie cor\u00e9enne\u00a0: 28\u00a0mm pour une compatibilit\u00e9 avec les plateaux cor\u00e9ens standard.<\/td>\n<\/tr>\n<tr style=\"background: #f0f9ff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">\u00e9paisseur de la paroi corporelle<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; font-weight: bold; color: #0369a1;\">0,30\u20130,40 mm<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd;\">Translucidit\u00e9 pour le contr\u00f4le du niveau de remplissage\u00a0; \u2264\u00a00,40\u00a0mm pour une translucidit\u00e9 suffisante du PEHD \u00e0 un volume de 10\u00a0ml<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">Pr\u00e9cision du volume<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; font-weight: bold;\">10,0 ml \u00b10,5 ml<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd;\">Tol\u00e9rance de volume de remplissage ophtalmique KFDA cor\u00e9enne \u2014 la position du rep\u00e8re de remplissage sur le contenant IBM doit refl\u00e9ter cette tol\u00e9rance \u00e0 23 \u00b0C<\/td>\n<\/tr>\n<tr style=\"background: #f0f9ff;\">\n<td style=\"padding: 9px 12px; font-weight: 600;\">Poids de la bouteille<\/td>\n<td style=\"padding: 9px 12px; text-align: center; font-weight: bold;\">2,5\u20134,5 g<\/td>\n<td style=\"padding: 9px 12px;\">Immatriculation en PEHD avec une \u00e9paisseur de paroi de 0,30 \u00e0 0,40 mm \u2014 plus l\u00e9ger que l'\u00e9quivalent EBM\u00a0; poids cavit\u00e9 \u00e0 cavit\u00e9 conforme aux sp\u00e9cifications CV% \u22644%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p style=\"font-size: 16px; margin-bottom: 0;\">The 13\/415 neck finish specification is critical for Korean ophthalmic IBM mould design: the 13 mm nominal neck OD and 415 thread count (15 threads per inch) are the international standard for ophthalmic dropper closures adopted by Korean ophthalmic pharmaceutical brands and Korean dropper cap manufacturers. IBM container moulds for Korean ophthalmic production must specify 13\/415 neck inserts in the injection mould to the same dimensional accuracy as the Korean dropper cap tooling \u2014 \u00b10.02 mm on the neck OD at the injection mould neck cavity insert ensures that the finished IBM bottle&#8217;s \u00b10.05 mm neck OD tolerance is achieved with process margin on both sides of the dropper cap engagement window.<\/p>\n<\/section>\n<p><!-- S3 --><\/p>\n<section id=\"s3\" style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #e5e7eb;\">\n<h2 style=\"font-size: clamp(18px,2.6vw,24px); font-weight: 800; color: #0369a1; margin: 0 0 18px;\">3. Pr\u00e9cision du col IBM pour l'engagement du bouchon compte-gouttes<\/h2>\n<figure style=\"margin: 0 0 22px;\"><img decoding=\"async\" style=\"width: 100%; height: auto; border-radius: 8px; display: block;\" title=\"IBM Ophthalmic Neck Mould Precision \u2014 Korea Ever-Power\" src=\"https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/07\/IBM-mold-2.webp\" alt=\"IBM injection blow molding mould precision \u2014 13\/415 ophthalmic neck insert in injection mould core rod assembly showing \u00b10.02mm neck OD cavity tolerance producing \u00b10.05mm IBM bottle neck OD across all 20-30 production cavities \u2014 Korea Ever-Power pharmaceutical ophthalmic mould S136 stainless steel neck insert for Korean KFDA ophthalmic dropper cap engagement qualification\" \/><figcaption style=\"font-size: 12px; color: #6b7280; margin-top: 8px; text-align: center;\">IBM ophthalmic neck precision \u2014 the injection mould&#8217;s 13\/415 neck insert (S136 stainless, HRC 50\u201352) defines the ophthalmic container neck at \u00b10.02 mm cavity dimensional tolerance, producing \u00b10.05 mm neck OD on finished IBM bottles across all 20\u201330 production cavities. The core rod holds the 9.0 mm bore ID throughout both injection and blow phases, ensuring the dropper insert engagement diameter is identical to the injection mould&#8217;s core rod OD regardless of blow air pressure variation between cycles.<\/figcaption><\/figure>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">The Korean ophthalmic dropper cap system has two precision interface points with the IBM container neck: the outer snap-fit or thread engagement between the dropper cap skirt and the neck OD, and the inner bore engagement between the dropper insert&#8217;s controlled orifice body and the neck bore ID. Both interfaces require dimensional precision that IBM provides natively through its injection mould tooling and core rod mechanism.<\/p>\n<h3 style=\"font-size: clamp(16px,2vw,20px); color: #0369a1; font-weight: bold; margin: 0 0 10px;\">Interface ext\u00e9rieure \u00e0 enclenchement rapide\u00a0: diam\u00e8tre ext\u00e9rieur du col \u00b10,05 mm<\/h3>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">Korean ophthalmic dropper caps engage the IBM bottle neck at the 13 mm OD by a circumferential bead on the cap skirt that snaps over the neck&#8217;s retaining flange. This snap-fit engagement provides: tamper evidence (the bead breaks an induction seal or deforms the retaining flange on first opening), child resistance (some Korean ophthalmic CRC formats require push-and-turn action), and closure retention during Korean pharmacy dispensing handling (the cap must remain attached to the bottle when tapped on a Korean pharmacy dispensing tray). The snap-fit mechanism&#8217;s function depends on the interference between the cap bead inner diameter and the bottle neck flange OD \u2014 the designed interference is typically 0.08\u20130.15 mm (the cap bead is 0.08\u20130.15 mm smaller in diameter than the neck flange OD). With IBM&#8217;s \u00b10.05 mm neck OD tolerance, the interference varies between 0.08\u20130.15 mm \u00b10.05 mm across all cavities \u2014 always within the range where snap-fit engagement occurs without cap opening force being excessive for Korean pharmacists or patients. With EBM&#8217;s \u00b10.15\u20130.25 mm neck OD tolerance, the interference variation of \u00b10.15\u20130.25 mm would produce, at the low end, engagement that is either absent (cap falls off) or, at the high end, engagement that requires destructive force to open \u2014 neither acceptable in Korean ophthalmic pharmaceutical distribution.<\/p>\n<h3 style=\"font-size: clamp(16px,2vw,20px); color: #0369a1; font-weight: bold; margin: 28px 0 10px;\">Interface de l'al\u00e9sage interne\u00a0: orifice d'insertion de la pipette \u00e0 \u00b10,04 mm<\/h3>\n<p style=\"font-size: 16px; margin-bottom: 0;\">The dropper insert \u2014 the controlled-orifice component that produces a consistent 25\u201335 microlitre drop volume per squeeze \u2014 seats inside the IBM bottle neck bore, with its outer body in contact with the bore inner surface. The drop volume delivered by the dropper insert depends on two factors: the orifice diameter (controlled by the dropper insert mould tooling) and the bore-insert interference fit (controlled by the IBM bore ID versus the dropper insert OD). If the IBM bore is too small (below nominal), the dropper insert compresses inward and distorts the orifice geometry \u2014 producing smaller drop volumes than specified. If the IBM bore is too large (above nominal), the dropper insert can tilt within the bore, creating asymmetric orifice orientation that produces erratic drop trajectory in Korean patient use. IBM&#8217;s core rod defines the bore ID at \u00b10.04 mm across all cavities through the direct mechanical relationship between the core rod OD and the bore it forms during injection \u2014 the bore is not blown, not stretched, not dependent on air pressure, and does not vary with process parameter fluctuation at the blow station.<\/p>\n<\/section>\n<p><!-- S4 --><\/p>\n<section id=\"s4\" style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #e5e7eb;\">\n<h2 style=\"font-size: clamp(18px,2.6vw,24px); font-weight: 800; color: #0369a1; margin: 0 0 18px;\">4. Qualit\u00e9 et traitement du PEHD pour l'IBM ophtalmique<\/h2>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">Les implants ophtalmiques cor\u00e9ens en PEHD utilisent une sp\u00e9cification de r\u00e9sine plus \u00e9troite que les implants pharmaceutiques g\u00e9n\u00e9raux\u00a0: la combinaison d\u2019une paroi mince (0,30 \u00e0 0,40\u00a0mm), d\u2019un nombre \u00e9lev\u00e9 de cavit\u00e9s (20 \u00e0 30\u00a0cavit\u00e9s), de longs canaux chauds et des exigences de la KFDA cor\u00e9enne en mati\u00e8re d\u2019extractibles cr\u00e9e un ensemble de sp\u00e9cifications qui restreint la gamme de qualit\u00e9s de PEHD utilisables \u00e0 un MI de 0,3 \u00e0 0,5 \u00e0 190\u00a0\u00b0C\/2,16\u00a0kg et \u00e0 une densit\u00e9 de 0,950 \u00e0 0,960\u00a0g\/cm\u00b3 pour la majorit\u00e9 des applications ophtalmiques cor\u00e9ennes.<\/p>\n<div style=\"display: flex; flex-wrap: wrap; gap: 14px; margin: 16px 0 24px;\">\n<div style=\"flex: 1 1 260px; background: #f0f9ff; border-left: 4px solid #0369a1; border-radius: 0 6px 6px 0; padding: 16px 20px;\">\n<p style=\"font-weight: bold; color: #0369a1; margin: 0 0 8px;\">Sp\u00e9cifications de qualit\u00e9 de la r\u00e9sine<\/p>\n<ul style=\"margin: 0; padding-left: 18px; display: flex; flex-direction: column; gap: 5px; font-size: 14px; color: #374151; line-height: 1.65;\">\n<li>MI : 0,3\u20130,5 g\/10 min (190 \u00b0C \/ 2,16 kg)<\/li>\n<li>Densit\u00e9 : 0,950\u20130,960 g\/cm\u00b3<\/li>\n<li>Additifs : uniquement ceux figurant sur la liste positive de la KFDA<\/li>\n<li>Sans stabilisateurs UV, sans agents de glissement<\/li>\n<li>Antioxydant : AO-1010 ou AO-168 \u2264 0,051 TP3T<\/li>\n<li>D\u00e9claration de contact pharmaceutique KFDA requise<\/li>\n<\/ul>\n<\/div>\n<div style=\"flex: 1 1 260px; background: #f0f9ff; border-left: 4px solid #0284c7; border-radius: 0 6px 6px 0; padding: 16px 20px;\">\n<p style=\"font-weight: bold; color: #0369a1; margin: 0 0 8px;\">Param\u00e8tres de traitement (ZQ80\/ZQ110)<\/p>\n<ul style=\"margin: 0; padding-left: 18px; display: flex; flex-direction: column; gap: 5px; font-size: 14px; color: #374151; line-height: 1.65;\">\n<li>F\u00fbt\u00a0: 175\u2192195\u2192210\u2192215\u2192215\u00b0C<\/li>\n<li>Pression d'injection : 90\u2013130 MPa<\/li>\n<li>Temps de remplissage : 0,6\u20131,0 s (paroi mince)<\/li>\n<li>Maintien : pic 50\u201365%, 0,4\u20130,8 s<\/li>\n<li>Pression de soufflage d'air : 0,5\u20130,8 MPa<\/li>\n<li>Dur\u00e9e de maintien de la pression : 0,7\u20131,2 s<\/li>\n<li>Temp\u00e9rature du moule : 12\u201322 \u00b0C<\/li>\n<\/ul>\n<\/div>\n<div style=\"flex: 1 1 260px; background: #f0f9ff; border-left: 4px solid #0ea5e9; border-radius: 0 6px 6px 0; padding: 16px 20px;\">\n<p style=\"font-weight: bold; color: #0369a1; margin: 0 0 8px;\">Contr\u00f4les de qualit\u00e9 critiques<\/p>\n<ul style=\"margin: 0; padding-left: 18px; display: flex; flex-direction: column; gap: 5px; font-size: 14px; color: #374151; line-height: 1.65;\">\n<li>Diam\u00e8tre ext\u00e9rieur du col : 13,00 \u00b10,05 mm \u2014 toutes cavit\u00e9s<\/li>\n<li>Diam\u00e8tre int\u00e9rieur de l'al\u00e9sage\u00a0: 9,0 \u00b10,04 mm \u2014 toutes cavit\u00e9s<\/li>\n<li>Poids de la bouteille : \u00b14% CV% \u00e0 travers les cavit\u00e9s<\/li>\n<li>Translucidit\u00e9 du mur : r\u00e9ussite du contr\u00f4le visuel du niveau de remplissage<\/li>\n<li>Fixation du bouchon de la tige de selle t\u00e9lescopique : 100% \u00e0 enclenchement rapide en ligne<\/li>\n<li>Particules : conformes aux normes ophtalmiques de la KFDA<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<p style=\"font-size: 16px; margin-bottom: 0;\"><strong>Interaction entre la translucidit\u00e9 de la paroi et la qualit\u00e9 du PEHD\u00a0:<\/strong> Korean ophthalmic containers must allow Korean pharmacists and Korean patients to visually inspect the liquid fill level \u2014 a requirement that limits HDPE wall thickness to \u22640.40 mm at the body panel, where HDPE&#8217;s semi-crystalline structure transmits sufficient light at this thickness for fill-level judgement. At 0.50 mm body wall, standard HDPE at density 0.955 g\/cm\u00b3 becomes opaque enough that fill-level inspection is unreliable. The 0.30\u20130.40 mm body wall is a design constraint that the IBM mould designer must achieve through the preform geometry and blow ratio \u2014 and that the IBM operator must verify in production through periodic wall thickness measurement at the minimum body wall location using ultrasonic gauge measurement.<\/p>\n<\/section>\n<p><!-- S5 --><\/p>\n<section id=\"s5\" style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #e5e7eb;\">\n<h2 style=\"font-size: clamp(18px,2.6vw,24px); font-weight: 800; color: #0369a1; margin: 0 0 18px;\">5. Exigences de qualification des contenants ophtalmiques de la KFDA cor\u00e9enne<\/h2>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">Les exigences de qualification des contenants de produits ophtalmiques de la KFDA cor\u00e9enne sont plus strictes que les exigences g\u00e9n\u00e9rales applicables aux contenants de produits pharmaceutiques dans deux domaines sp\u00e9cifiques\u00a0: les normes de contamination particulaire et la dur\u00e9e des tests de compatibilit\u00e9. Ces exigences plus rigoureuses tiennent compte de la voie d\u2019administration ophtalmique\u00a0: la surface oculaire est extr\u00eamement sensible aux agressions particulaires et chimiques, et les normes de s\u00e9curit\u00e9 des produits ophtalmiques de la KFDA cor\u00e9enne sont adapt\u00e9es en cons\u00e9quence.<\/p>\n<h3 style=\"font-size: clamp(16px,2vw,20px); color: #0369a1; font-weight: bold; margin: 0 0 10px;\">Normes relatives aux particules ophtalmiques (KFDA \/ Pharmacop\u00e9e cor\u00e9enne)<\/h3>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">Korean Pharmacopoeia (KP) aligns with USP &lt;790&gt; for visible particulates in ophthalmic preparations and USP &lt;788&gt; for sub-visible particulate matter in ophthalmic preparations. For Korean IBM ophthalmic container qualification, particulate testing applies in two stages: container wash-extract testing (empty containers filled with purified water, agitated and examined for visible particulate and sub-visible particulate count) and filled product testing (Korean ophthalmic formulation filled into IBM containers examined at end of proposed shelf life). IBM container wash-extract particulate limits per KP ophthalmic container test: visible particles \u2014 absent (zero visible particles in wash extract when examined under Korean Pharmacopoeia visible inspection method); sub-visible particles per KP (aligned with USP &lt;788&gt;): \u226425 particles\/ml \u226510 \u03bcm, \u22643 particles\/ml \u226525 \u03bcm. IBM&#8217;s zero-flash production eliminates the most significant source of sub-visible particulate in blow-moulded pharmaceutical containers \u2014 the plastic fines generated by EBM flash trimming. Korea Ever-Power&#8217;s pharmaceutical IBM documentation package includes a reference statement on IBM&#8217;s zero-flash architecture for use in the Korean pharmaceutical container qualification documentation that addresses Korean KFDA questions on particle contamination prevention during container production.<\/p>\n<h3 style=\"font-size: clamp(16px,2vw,20px); color: #0369a1; font-weight: bold; margin: 28px 0 10px;\">Dur\u00e9e des tests de compatibilit\u00e9 pour les conteneurs IBM ophtalmiques<\/h3>\n<p style=\"font-size: 16px; margin-bottom: 0;\">Korean KFDA ophthalmic pharmaceutical container compatibility testing requires a 24-month accelerated stability study at 40\u00b0C\/75% RH \u2014 12 months longer than the 12-month standard for most oral pharmaceutical container compatibility studies. The longer study period reflects the Korean KFDA position that ophthalmic formulations&#8217; complex mixture of active ingredients, preservatives (benzalkonium chloride, thimerosal, or preservative-free buffer systems) and buffering agents creates a more complex extractable interaction profile with HDPE than simple aqueous solutions. Korean IBM ophthalmic packaging producers should plan for 24-month compatibility studies \u2014 which means beginning the filled container compatibility study immediately upon first IBM production at qualification conditions, so that the 24-month study result is available within the overall Korean ophthalmic product development timeline without delaying the KFDA submission.<\/p>\n<\/section>\n<p><!-- S6 --><\/p>\n<section id=\"s6\" style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #e5e7eb;\">\n<h2 style=\"font-size: clamp(18px,2.6vw,24px); font-weight: 800; color: #0369a1; margin: 0 0 18px;\">6. Installation d'une salle blanche IBM pour la production ophtalmique cor\u00e9enne<\/h2>\n<figure style=\"margin: 0 0 22px;\"><img decoding=\"async\" style=\"width: 100%; height: auto; border-radius: 8px; display: block;\" title=\"IBM Ophthalmic Cleanroom Production Line \u2014 Korea Ever-Power\" src=\"https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/07\/IBM-PRODUCTION-LINE-COMPONENTS.webp\" alt=\"Korea Ever-Power IBM ophthalmic pharmaceutical production line \u2014 ZQ series machine with HEPA positive-pressure cleanroom enclosure over mould area dual chiller mould temperature controllers oil-free air compressor output conveyor for Korean KFDA ophthalmic container production in ISO Class 8 cleanroom environment\" \/><figcaption style=\"font-size: 12px; color: #6b7280; margin-top: 8px; text-align: center;\">Composants de la ligne de production ophtalmique Korea Ever-Power IBM \u2014 la cellule de production compl\u00e8te pour la production de contenants ophtalmiques KFDA cor\u00e9ens comprend la machine de la s\u00e9rie ZQ avec enceinte HEPA au-dessus du poste de moulage et du convoyeur de sortie, un compresseur sans huile (obligatoire pour l'alimentation en air de qualit\u00e9 ophtalmique), un double refroidisseur pour les circuits de temp\u00e9rature ind\u00e9pendants des moules d'injection et de soufflage, et un convoyeur de sortie filtr\u00e9 HEPA pour maintenir la propret\u00e9 jusqu'au poste de palettisation.<\/figcaption><\/figure>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">La production cor\u00e9enne de dispositifs ophtalmiques \u00e0 base d'IBM est g\u00e9n\u00e9ralement r\u00e9alis\u00e9e en salles blanches de classe ISO 8 (\u00e9quivalent \u00e0 la norme cor\u00e9enne GMP de grade D). Les exigences sp\u00e9cifiques en mati\u00e8re de salles blanches pour la production de ces dispositifs \u2014 diff\u00e9rentes de celles des salles blanches pharmaceutiques classiques d\u00e9crites dans le guide relatif aux dispositifs ophtalmiques \u00e0 base d'IBM \u2014 tiennent compte de la plus grande sensibilit\u00e9 aux particules de ces dispositifs.<\/p>\n<ul style=\"margin: 0 0 24px; padding-left: 20px; display: flex; flex-direction: column; gap: 12px;\">\n<li style=\"font-size: 16px; color: #374151; line-height: 1.7;\"><strong style=\"color: #0369a1;\">Alimentation en air HEPA au-dessus de la station de traitement des moisissures\u00a0:<\/strong> The IBM machine&#8217;s mould area \u2014 where containers are formed and where the core rods deposit finished containers onto the output conveyor \u2014 should receive HEPA-filtered supply air at \u22650.45 m\/s face velocity downward into the open mould area. This positive-pressure HEPA supply air prevents airborne particles from entering the open container mouth during the time between stripping (Station 3) and cap application at the downstream Korean pharmaceutical filling line. The HEPA enclosure over the mould station is specified as a separate engineering item in the Korean ophthalmic IBM cell design \u2014 Korea Ever-Power provides connection points and dimensional data for the HEPA enclosure installation on the ZQ machine outline drawings.<\/li>\n<li style=\"font-size: 16px; color: #374151; line-height: 1.7;\"><strong style=\"color: #0369a1;\">Air comprim\u00e9 sans huile \u2014 obligatoire\u00a0:<\/strong> L'air comprim\u00e9 utilis\u00e9 pour le soufflage IBM des contenants ophtalmiques cor\u00e9ens doit \u00eatre exempt d'huile au point d'utilisation (norme ISO 8573-1, classe 0 pour les a\u00e9rosols et vapeurs d'huile). Toute contamination huileuse de l'air de soufflage IBM au niveau de la station de soufflage entre en contact avec la face interne de la pr\u00e9forme en PEHD lors du gonflage et devient un contaminant extractible dans le contenant fini. Les fabricants cor\u00e9ens de contenants ophtalmiques IBM doivent imp\u00e9rativement utiliser des compresseurs \u00e0 vis sans huile (et non des compresseurs \u00e0 piston lubrifi\u00e9s \u00e0 l'huile avec filtres en aval) et v\u00e9rifier l'absence d'huile au point de raccordement de la machine par une surveillance r\u00e9guli\u00e8re des particules et des vapeurs d'huile, conform\u00e9ment aux protocoles cor\u00e9ens de contr\u00f4le de la qualit\u00e9 de l'air comprim\u00e9 pharmaceutique.<\/li>\n<li style=\"font-size: 16px; color: #374151; line-height: 1.7;\"><strong style=\"color: #0369a1;\">Enceinte HEPA du convoyeur de sortie\u00a0:<\/strong> Les flacons ophtalmiques cor\u00e9ens sortant de la machine IBM \u00e0 la station 3 sont achemin\u00e9s par un convoyeur de sortie avant d'\u00eatre conditionn\u00e9s en sacs ou plateaux pour \u00eatre transport\u00e9s vers la ligne de remplissage pharmaceutique cor\u00e9enne. Cette section du convoyeur doit \u00eatre \u00e9quip\u00e9e d'un syst\u00e8me de filtration HEPA afin de garantir la propret\u00e9 des flacons depuis la sortie de la machine IBM jusqu'au point de collecte. Ce syst\u00e8me est g\u00e9n\u00e9ralement install\u00e9 sous forme de tunnel avec une alimentation en air filtr\u00e9 HEPA sous pression positive et un syst\u00e8me d'\u00e9vacuation filtr\u00e9 \u00e0 la sortie du convoyeur. Sans ce syst\u00e8me, les flacons ophtalmiques cor\u00e9ens IBM peuvent accumuler des particules en suspension dans l'air pendant leur transport sur le convoyeur. Ces particules se d\u00e9posent ensuite dans l'ouverture du flacon et contribuent \u00e0 la pr\u00e9sence de particules subvisibles dans le flacon rempli.<\/li>\n<\/ul>\n<\/section>\n<p><!-- S7 --><\/p>\n<section id=\"s7\" style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #e5e7eb;\">\n<h2 style=\"font-size: clamp(18px,2.6vw,24px); font-weight: 800; color: #0369a1; margin: 0 0 18px;\">7. Analyse \u00e9conomique du nombre de caries pour l'ophtalmologie cor\u00e9enne (IBM)<\/h2>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">Cavity count selection for Korean ophthalmic IBM is the highest-impact single investment decision \u2014 because the Korean ophthalmic container market&#8217;s 500M+ annual unit demand requires matching machine cavity count to annual production volume with enough precision that the machine runs at 70\u201390% utilisation (below 60% utilisation wastes capital; above 90% utilisation creates production risk from unscheduled maintenance). The following analysis compares three ZQ models for a Korean ophthalmic contract packaging factory with a specific annual volume requirement.<\/p>\n<div style=\"overflow-x: auto; margin: 16px 0 24px;\">\n<table style=\"width: 100%; border-collapse: collapse; font-size: 13.5px; min-width: 500px;\">\n<thead>\n<tr style=\"background: #0369a1;\">\n<th style=\"color: #fff; padding: 10px 12px; text-align: left; font-weight: bold;\">Param\u00e8tre<\/th>\n<th style=\"color: #fff; padding: 10px 12px; text-align: center; font-weight: bold;\">ZQ80 (20 cav)<\/th>\n<th style=\"color: #fff; padding: 10px 12px; text-align: center; font-weight: bold;\">ZQ110 (24 cav)<\/th>\n<th style=\"color: #fff; padding: 10px 12px; text-align: center; font-weight: bold;\">ZQ135 (30 cav)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">Bouteilles\/heure (88% eff.)<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center;\">~15,840<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; font-weight: bold; color: #0369a1;\">~19,000<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; font-weight: bold; color: #0369a1;\">~23,760<\/td>\n<\/tr>\n<tr style=\"background: #f0f9ff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">Bouteilles\/Cor\u00e9en Journ\u00e9e de travail en 2 \u00e9quipes (14 h)<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center;\">~221,760<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center;\">~266,000<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center;\">~332,640<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">Bouteilles\/an (250 jours)<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center;\">~55,4 millions<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; font-weight: bold; color: #0369a1;\">~66,5 millions<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; font-weight: bold; color: #0369a1;\">~83,2 millions<\/td>\n<\/tr>\n<tr style=\"background: #f0f9ff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">Machines pour 200 millions d'unit\u00e9s par an<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center;\">4 machines<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center;\">3 machines<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; font-weight: bold; color: #0369a1;\">3 machines (72% util.)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 9px 12px; font-weight: 600;\">Qualifications KFDA requises<\/td>\n<td style=\"padding: 9px 12px; text-align: center; color: #dc2626;\">4 machines qualifi\u00e9es<\/td>\n<td style=\"padding: 9px 12px; text-align: center; color: #f59e0b;\">3 machines qualifi\u00e9es<\/td>\n<td style=\"padding: 9px 12px; text-align: center; color: #166534; font-weight: bold;\">3 qualifications machine (la plus basse par unit\u00e9)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p style=\"font-size: 16px; margin-bottom: 0;\">Le tableau comparatif des co\u00fbts en fonction du nombre de cavit\u00e9s montre que pour un conditionneur ophtalmique cor\u00e9en visant une production annuelle de 200 millions d'unit\u00e9s de 10 ml, la ZQ135 \u00e0 30 cavit\u00e9s n\u00e9cessite le m\u00eame nombre de machines que la ZQ110 \u00e0 24 cavit\u00e9s (3 machines dans les deux cas), mais avec un taux d'utilisation de 721 TP3T contre 1001 TP3T. Ceci offre une marge de production suffisante pour les maintenances impr\u00e9vues, les arr\u00eats li\u00e9s aux changements de format et la croissance annuelle de la demande, sans n\u00e9cessiter l'achat d'une quatri\u00e8me machine. Le nombre de qualifications machine KFDA est \u00e9galement minimis\u00e9 avec un nombre de cavit\u00e9s plus \u00e9lev\u00e9 (3 qualifications pour la ZQ135 contre 4 pour la ZQ80)\u00a0; chaque qualification repr\u00e9sente 16 \u00e0 24 semaines de tests et un co\u00fbt de documentation important. Pour les entreprises de conditionnement ophtalmique cor\u00e9ennes cherchant \u00e0 minimiser le nombre total de qualifications machine KFDA tout en maintenant une redondance de production, la ZQ135 ou la ZQ110 repr\u00e9sente clairement l'investissement le plus judicieux par rapport \u00e0 plusieurs machines ZQ80 pour une production annuelle \u00e9quivalente. <a style=\"color: #0369a1; font-weight: 600; text-decoration: none;\" href=\"https:\/\/isbm-blow-molding.com\/fr\/product\/ep-zq110-injection-blow-molding-machine-european-style\/\">EP-ZQ110<\/a> est la plateforme de d\u00e9part la plus courante pour les entreprises cor\u00e9ennes de conditionnement \u00e0 fa\u00e7on de produits ophtalmiques dont le volume annuel se situe entre 50 et 80 millions d'unit\u00e9s par machine.<\/p>\n<\/section>\n<p><!-- S8 --><\/p>\n<section id=\"s8\" style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #e5e7eb;\">\n<h2 style=\"font-size: clamp(18px,2.6vw,24px); font-weight: 800; color: #0369a1; margin: 0 0 18px;\">8. S\u00e9lection de la s\u00e9rie ZQ pour la production cor\u00e9enne d'IBM ophtalmique<\/h2>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">Pour la production cor\u00e9enne de dispositifs ophtalmiques IBM, le choix entre les mod\u00e8les de la s\u00e9rie ZQ d\u00e9pend non seulement du d\u00e9bit de production et du co\u00fbt d'investissement, mais aussi d'une contrainte sp\u00e9cifique au secteur pharmaceutique\u00a0: l'homologation KFDA cor\u00e9enne est li\u00e9e au mod\u00e8le de machine et au nombre de cavit\u00e9s. Les recommandations suivantes tiennent compte de cette contrainte.<\/p>\n<div style=\"display: flex; flex-direction: column; gap: 12px; margin: 16px 0 24px;\">\n<div style=\"background: #f0f9ff; border-radius: 8px; padding: 18px 22px; border-left: 4px solid #0369a1;\">\n<p style=\"font-weight: bold; color: #0369a1; margin: 0 0 8px;\">Start-up ophtalmique cor\u00e9enne \/ Production d'essai \u2192 ZQ60 (14 cavit\u00e9s)<\/p>\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.65;\">Volume annuel inf\u00e9rieur \u00e0 25 millions d'unit\u00e9s. Jeunes entreprises pharmaceutiques cor\u00e9ennes, essais pilotes de lignes de production ophtalmiques cor\u00e9ennes, production d'essai par des sous-traitants cor\u00e9ens pour des marques ophtalmiques internationales s'implantant en Cor\u00e9e. L'investissement dans la ZQ60 convient aux volumes inf\u00e9rieurs \u00e0 25 millions d'unit\u00e9s, mais exige une planification rigoureuse\u00a0: la mise \u00e0 niveau de la ZQ60 vers la ZQ80 pour un produit ophtalmique cor\u00e9en d\u00e9j\u00e0 enregistr\u00e9 aupr\u00e8s de la KFDA n\u00e9cessite une nouvelle notification de changement de machine aupr\u00e8s de la KFDA et une qualification sur la nouvelle machine \u2013 un processus de 3 \u00e0 6 mois. Les fabricants cor\u00e9ens d'emballages ophtalmiques qui pr\u00e9voient une croissance de plus de 30 millions d'unit\u00e9s dans les 3 ans devraient opter pour la ZQ80 d\u00e8s le d\u00e9part et accepter le taux d'utilisation initial plus faible, \u00e9vitant ainsi les co\u00fbts de transition li\u00e9s \u00e0 la qualification.<\/p>\n<\/div>\n<div style=\"background: #f0f9ff; border-radius: 8px; padding: 18px 22px; border-left: 4px solid #0284c7;\">\n<p style=\"font-weight: bold; color: #0369a1; margin: 0 0 8px;\">Ophtalmique cor\u00e9en de milieu de gamme \u2192 ZQ80 (20 cavit\u00e9s, 30 \u00e0 55 millions d'unit\u00e9s\/an)<\/p>\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.65;\">The ZQ80&#8217;s dual hydraulic system (20\u201330% energy saving) and high-precision angle divider (standard at ZQ80+) make it the entry point for Korean ophthalmic production where energy efficiency and inter-cavity consistency are KFDA qualification requirements. At 20-cavity 10 ml production, ZQ80 produces approximately 55M ophthalmic bottles per Korean two-shift year \u2014 sufficient for Korean mid-scale pharmaceutical manufacturers serving Korean domestic ophthalmic market without export requirements.<\/p>\n<\/div>\n<div style=\"background: #f0f9ff; border-radius: 8px; padding: 18px 22px; border-left: 4px solid #0ea5e9;\">\n<p style=\"font-weight: bold; color: #0369a1; margin: 0 0 8px;\">Ophtalmologie cor\u00e9enne \u00e0 grande \u00e9chelle \u2192 ZQ110 \/ ZQ135 (55M\u201383M+ unit\u00e9s\/an par machine)<\/p>\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.65;\">Les entreprises cor\u00e9ennes de conditionnement pharmaceutique \u00e0 fa\u00e7on qui travaillent pour des marques ophtalmiques multinationales, les exportateurs pharmaceutiques cor\u00e9ens et les fabricants ophtalmiques nationaux cor\u00e9ens qui approvisionnent les cha\u00eenes d'approvisionnement hospitali\u00e8res cor\u00e9ennes \u00e0 l'\u00e9chelle nationale \u2014 tous ont besoin de la production de ZQ110 ou de ZQ135 pour atteindre les volumes de production et l'efficacit\u00e9 de qualification KFDA requis par leur mod\u00e8le commercial. <a style=\"color: #0369a1; font-weight: 600; text-decoration: none;\" href=\"https:\/\/isbm-blow-molding.com\/fr\/product-category\/injection-blow-molding-machine\/\">gamme compl\u00e8te de machines de moulage par injection-soufflage<\/a> Ce document couvre toutes les \u00e9chelles de production ophtalmique cor\u00e9enne, de la start-up \u00e0 l'approvisionnement pharmaceutique \u00e0 l'\u00e9chelle nationale.<\/p>\n<\/div>\n<\/div>\n<\/section>\n<p><!-- FAQ --><\/p>\n<section style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #0369a1;\">\n<h2 id=\"faq\" style=\"font-size: clamp(19px,2.8vw,25px); font-weight: 800; color: #0369a1; margin: 0 0 24px;\">Foire aux questions<\/h2>\n<div style=\"display: flex; flex-direction: column; gap: 2px;\">\n<div style=\"border: 1px solid #bae6fd; border-radius: 8px 8px 0 0; overflow: hidden;\">\n<div style=\"background: #f0f9ff; padding: 14px 20px; border-bottom: 1px solid #bae6fd;\">\n<p style=\"font-size: 15px; font-weight: bold; color: #0369a1; margin: 0;\">Q1 \u2014 Qu\u2019est-ce qui diff\u00e9rencie techniquement les flacons IBM ophtalmiques de 10 ml des autres flacons IBM pharmaceutiques\u00a0?<\/p>\n<\/div>\n<div style=\"padding: 16px 20px;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.7;\">10 ml ophthalmic IBM containers have four specific technical requirements that distinguish them from other pharmaceutical IBM containers. First, dual precision neck interface: ophthalmic containers require precision at both the outer neck OD (dropper cap snap-fit engagement at \u00b10.05 mm) and the inner neck bore (dropper insert orifice body at \u00b10.04 mm) simultaneously \u2014 most other pharmaceutical IBM containers require only outer neck OD precision for closure engagement. Second, body wall translucency: ophthalmic containers must allow visual fill-level inspection at 0.30\u20130.40 mm body wall \u2014 the thinnest wall specification in pharmaceutical IBM and one that requires specific preform design and blow ratio optimisation. Third, stricter particulate standards: Korean KFDA ophthalmic sub-visible particulate limits (\u226425 particles\/ml \u226510 \u03bcm) are more stringent than general pharmaceutical container particulate limits, requiring HEPA-enclosed production and oil-free compressed air at the IBM machine. Fourth, 24-month compatibility study: Korean KFDA ophthalmic container compatibility testing requires 24-month accelerated stability at 40\u00b0C\/75% RH versus 12 months for most oral pharmaceutical containers \u2014 doubling the qualification timeline for the compatibility component. Together, these four characteristics make 10 ml ophthalmic IBM the most technically demanding standard pharmaceutical IBM format, and the format where Korea Ever-Power&#8217;s pharmaceutical IBM expertise provides the most value in guiding mould design, machine specification and qualification documentation preparation.<\/p>\n<\/div>\n<\/div>\n<div style=\"border: 1px solid #bae6fd; border-top: none; overflow: hidden;\">\n<div style=\"background: #f0f9ff; padding: 14px 20px; border-bottom: 1px solid #bae6fd;\">\n<p style=\"font-size: 15px; font-weight: bold; color: #0369a1; margin: 0;\">Q2 \u2014 La m\u00eame machine IBM et le m\u00eame moule peuvent-ils produire des r\u00e9cipients ophtalmiques de 10 ml et de 15 ml ?<\/p>\n<\/div>\n<div style=\"padding: 16px 20px;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.7;\">Yes, but with important constraints. IBM moulds are specific to a container geometry \u2014 the injection mould, blow mould, and stripping tool are all designed and manufactured for a specific container shape, volume and neck finish. Running both 10 ml and 15 ml ophthalmic containers on the same IBM machine requires two separate mould sets (one per container format) with a mould change procedure between formats. The IBM machine is format-flexible by design: Korea Ever-Power&#8217;s ZQ series machines accommodate any mould set within the machine&#8217;s platen dimensions and shot weight range, so a ZQ80 qualified for 10 ml ophthalmic can also run a 15 ml ophthalmic mould set after a mould change. However, each container format requires its own Korean KFDA pharmaceutical container qualification \u2014 the 10 ml qualification does not extend to 15 ml because the container drawing, neck dimensions, volume and wall thickness all differ between formats. Korean pharmaceutical IBM producers who produce multiple ophthalmic formats on the same machine must maintain separate KFDA qualification documentation for each format, including separate cavit-by-cavity dimensional reports and separate compatibility test reports. Mould change time between ophthalmic IBM formats on the ZQ series is typically 3\u20135 hours for trained operators \u2014 the heaviest component of ophthalmic mould change is the 20\u201330 cavity injection mould assembly, which requires a floor-mounted crane rated for 80\u2013150 kg (depending on cavity count) at the customer&#8217;s facility.<\/p>\n<\/div>\n<\/div>\n<div style=\"border: 1px solid #bae6fd; border-top: none; overflow: hidden;\">\n<div style=\"background: #f0f9ff; padding: 14px 20px; border-bottom: 1px solid #bae6fd;\">\n<p style=\"font-size: 15px; font-weight: bold; color: #0369a1; margin: 0;\">Q3 \u2014 How does Korean KFDA validate the IBM ophthalmic container&#8217;s dropper cap engagement across all cavities?<\/p>\n<\/div>\n<div style=\"padding: 16px 20px;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.7;\">La qualification des contenants pharmaceutiques cor\u00e9ens (KFDA) pour la fixation des bouchons compte-gouttes ophtalmiques est valid\u00e9e par trois tests document\u00e9s dans le dossier technique du contenant. Premi\u00e8rement, la conformit\u00e9 dimensionnelle : tous les compartiments doivent pr\u00e9senter un diam\u00e8tre ext\u00e9rieur du col conforme \u00e0 la sp\u00e9cification de \u00b10,05 mm. Cette conformit\u00e9 est v\u00e9rifi\u00e9e en mesurant 30 contenants de chaque compartiment sur 3 lots de production (90 mesures par compartiment au total) et en confirmant que toutes les mesures sont conformes \u00e0 la sp\u00e9cification, sans valeurs aberrantes. Deuxi\u00e8mement, le test fonctionnel de fixation du bouchon compte-gouttes : 200 contenants sont remplis d'eau distill\u00e9e, ferm\u00e9s avec le bouchon compte-gouttes cor\u00e9en sp\u00e9cifi\u00e9 et test\u00e9s pour : (a) la r\u00e9tention du bouchon sous une force de traction axiale de 10 N (simulant la manipulation par un pharmacien cor\u00e9en) ; (b) la force de retrait du bouchon dans la plage de sp\u00e9cification (ne n\u00e9cessitant pas une force excessive pour l'ouverture par le patient) ; (c) le volume de chaque goutte d\u00e9livr\u00e9e par l'orifice du compte-gouttes (25 \u00e0 35 \u00b5l), conform\u00e9ment aux exigences de formulation pharmaceutique cor\u00e9ennes. Troisi\u00e8mement, l'int\u00e9grit\u00e9 du scellage par induction (le cas \u00e9ch\u00e9ant) : les contenants scell\u00e9s avec une feuille d'induction sont test\u00e9s selon la norme ASTM F2096 (test de bulles), confirmant l'\u00e9tanch\u00e9it\u00e9 sur 1001 unit\u00e9s test\u00e9es (TP3T). Korea Ever-Power fournit les r\u00e9sultats des tests fonctionnels d'engagement du bouchon compte-gouttes avant livraison issus de l'essai de production dans le cadre du package de documentation standard \u2014 les \u00e9quipes d'assurance qualit\u00e9 des marques pharmaceutiques cor\u00e9ennes peuvent utiliser ces r\u00e9sultats comme donn\u00e9es de test fonctionnel du premier lot dans leur dossier technique de qualification des contenants KFDA, r\u00e9duisant ainsi le temps n\u00e9cessaire \u00e0 la compilation de la documentation de qualification apr\u00e8s l'installation de la machine.<\/p>\n<\/div>\n<\/div>\n<div style=\"border: 1px solid #bae6fd; border-top: none; overflow: hidden;\">\n<div style=\"background: #f0f9ff; padding: 14px 20px; border-bottom: 1px solid #bae6fd;\">\n<p style=\"font-size: 15px; font-weight: bold; color: #0369a1; margin: 0;\">Q4 \u2014 Quelles sont les causes de la d\u00e9faillance du bouchon compte-gouttes dans les contenants ophtalmiques IBM cor\u00e9ens et comment y rem\u00e9dier ?<\/p>\n<\/div>\n<div style=\"padding: 16px 20px;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.7;\">Korean ophthalmic IBM container dropper cap retention failure \u2014 where the dropper cap separates from the bottle during Korean pharmacy dispensing handling or Korean patient use \u2014 has two root causes from the IBM container side. First, neck OD below specification minimum: if the IBM container neck OD is below 12.95 mm (13.00 mm nominal minus 0.05 mm tolerance minimum), the dropper cap&#8217;s retention bead does not engage the neck flange with sufficient interference \u2014 the bead slides over the flange without snapping into the retention groove, producing a container that appears capped but releases under minor handling force. Diagnostic: measure all cavities&#8217; neck OD. If specific cavities are consistently below 12.95 mm, the problem is the injection mould neck insert for those cavities \u2014 either dimensional error in the insert or wear in the insert after extended production. Corrective action: regrind or replace the undersized neck cavity insert. Second, neck flange profile insufficiently defined: if the injection mould&#8217;s neck insert flange radius or flange height is below specification \u2014 typically from tool wear after 2\u20133 million cycles in a high-production ophthalmic mould \u2014 the dropper cap bead has no sharp flange edge to engage against, producing low retention force even when neck OD is within specification. Diagnostic: visual inspection of the neck flange profile under 10\u00d7 magnification, comparing to the original mould drawing. Corrective action: neck insert regrind to restore flange sharpness (possible 2\u20133 times before insert replacement is required) or neck insert replacement. Korea Ever-Power&#8217;s mould service team provides neck insert inspection and regrind services for Korean ophthalmic IBM moulds under the machine&#8217;s standard service contract.<\/p>\n<\/div>\n<\/div>\n<div style=\"border: 1px solid #bae6fd; border-top: none; overflow: hidden;\">\n<div style=\"background: #f0f9ff; padding: 14px 20px; border-bottom: 1px solid #bae6fd;\">\n<p style=\"font-size: 15px; font-weight: bold; color: #0369a1; margin: 0;\">Q5 \u2014 De combien de machines ZQ110 un sous-traitant cor\u00e9en de conditionnement ophtalmique a-t-il besoin pour produire 300 millions de contenants par an ?<\/p>\n<\/div>\n<div style=\"padding: 16px 20px;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.7;\">A Korean ophthalmic contract packager targeting 300 million 10 ml containers per year on ZQ110 machines (24 cavities, approximately 19,000 bottles per hour at 88% efficiency, approximately 66.5M containers per Korean two-shift year per machine) needs: 300M \u00f7 66.5M \u2248 4.5 machines \u2014 in practice, 5 ZQ110 machines at 90% of capacity, or 4 ZQ110 machines at 113% of capacity (impossible without a third Korean shift). The practical recommendation for a 300M unit annual requirement on ZQ110 is 5 machines, giving 332.5M annual capacity at 90% utilisation \u2014 10.8% headroom for unscheduled maintenance and demand growth. Five ZQ110 machines also require 5 Korean KFDA machine qualifications. An alternative \u2014 and commercially more efficient \u2014 approach for a 300M annual target is 4 ZQ135 machines: 4 \u00d7 83.2M = 332.8M annual capacity at 90% utilisation, with the same 5 million units headroom but only 4 KFDA machine qualifications (saving one qualification cycle). Korea Ever-Power&#8217;s application engineering team runs these comparative machine count analyses for Korean ophthalmic contract packaging facilities evaluating total cost of ownership, KFDA qualification cost and production flexibility between multiple ZQ110 and fewer ZQ135 configurations.<\/p>\n<\/div>\n<\/div>\n<div style=\"border: 1px solid #bae6fd; border-radius: 0 0 8px 8px; overflow: hidden;\">\n<div style=\"background: #f0f9ff; padding: 14px 20px; border-bottom: 1px solid #bae6fd;\">\n<p style=\"font-size: 15px; font-weight: bold; color: #0369a1; margin: 0;\">Q6 \u2014 Est-il possible de produire des contenants ophtalmiques IBM cor\u00e9ens en PEHD pigment\u00e9 (ambre) pour les formulations sensibles aux UV\u00a0?<\/p>\n<\/div>\n<div style=\"padding: 16px 20px;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.7;\">Yes, but pigmented Korean ophthalmic IBM containers require additional qualification steps versus natural HDPE ophthalmic containers. Amber HDPE for Korean ophthalmic IBM uses iron oxide-based amber masterbatch at 0.3\u20130.8% LDR in HDPE \u2014 iron oxide is on the Korean KFDA positive list for pharmaceutical packaging materials as an approved colourant. The pigment addition affects: extractables profile (additional extractables testing required for the pigmented grade versus natural HDPE \u2014 the amber masterbatch carrier resin and dispersion additives must be evaluated for Korean KFDA extractables compliance separately from the base HDPE resin); body wall translucency (amber pigment reduces visible light transmission further than natural HDPE at the same wall thickness, which is acceptable for UV-sensitive Korean ophthalmic formulations that require UV protection but means fill-level inspection must use a lightbox or specific lighting condition); and IBM processing (the masterbatch must be well-dispersed in the HDPE before IBM processing \u2014 poor dispersion creates visible pigment streaks in the amber bottle wall at the thin body panel zone, which is an appearance defect for Korean pharmacy dispensing). Korean ophthalmic pharmaceutical products that specify amber IBM containers typically include photosensitive Korean ophthalmic antibiotic preparations, certain Korean anti-inflammatory ophthalmic drops with UV-degradable active ingredients, and Korean ophthalmic diagnostic agents. The Korean pharmaceutical brand&#8217;s photostability data for the active ingredient (ICH Q1B photostability testing) should confirm whether an amber container is required or whether natural HDPE (which absorbs UV below 320 nm inherently at 0.35 mm wall) provides sufficient UV protection at the Korean ophthalmic product&#8217;s proposed storage conditions.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<p><!-- CTA --><\/p>\n<div style=\"background: linear-gradient(135deg,#03111e 0%,#0369a1 100%); border-radius: 10px; padding: clamp(30px,5vw,50px) clamp(20px,4vw,40px); text-align: center; margin: 56px 0 48px;\">\n<p style=\"font-size: 10px; font-weight: bold; letter-spacing: 2px; text-transform: uppercase; color: #7dd3fc; margin: 0 0 12px;\">Demande de renseignements sur l'IBM ophtalmique<\/p>\n<h2 style=\"font-size: clamp(18px,3vw,26px); font-weight: 800; color: #fff; margin: 0 0 14px;\">Planification de la production de conteneurs ophtalmiques cor\u00e9ens par IBM\u00a0?<\/h2>\n<p style=\"font-size: 15px; color: #bae6fd; max-width: 480px; margin: 0 auto 26px; line-height: 1.65;\">Korea Ever-Power fournit la conception de moules IBM ophtalmiques de 10 ml, la documentation de qualification KFDA cor\u00e9enne, la planification des cellules de production en salle blanche et la s\u00e9lection de machines de la s\u00e9rie ZQ pour l'emballage de produits pharmaceutiques ophtalmiques et de soins oculaires OTC cor\u00e9ens, quel que soit le volume de production annuel.<\/p>\n<p><a style=\"display: inline-block; background: #f97316; color: #fff; padding: 14px 36px; border-radius: 6px; text-decoration: none; font-weight: bold; font-size: 15px;\" href=\"https:\/\/isbm-blow-molding.com\/fr\/contact-us\/\">Demande de consultation ophtalmologique IBM<\/a><\/p>\n<\/div>\n<p><!-- RELATED RESOURCES --><\/p>\n<section style=\"margin-bottom: 56px;\">\n<p style=\"font-size: 10.5px; font-weight: bold; letter-spacing: 2px; text-transform: uppercase; color: #0369a1; margin-bottom: 16px;\">Ressources connexes<\/p>\n<div style=\"display: flex; flex-wrap: wrap; gap: 16px;\">\n<div style=\"background: #fff; border: 1.5px solid #bae6fd; border-top: 4px solid #0369a1; border-radius: 8px; padding: 18px 20px;\"><span style=\"display: block; font-size: 9px; font-weight: bold; color: #f97316; letter-spacing: 1.5px; text-transform: uppercase; margin-bottom: 8px;\">IBM ophtalmique de taille moyenne<\/span><br \/>\n<span style=\"display: block; font-size: 15px; font-weight: bold; color: #1e3a8a; margin-bottom: 8px; line-height: 1.3;\">Machine de moulage par injection-soufflage EP-ZQ80<\/span><br \/>\n<span style=\"display: block; font-size: 13px; color: #6b7280; line-height: 1.55;\">800 KN \u00b7 20 cavit\u00e9s \u00e0 10 ml ophtalmiques \u00b7 Diviseur d'angle + double standard hydraulique \u00b7 ~55 millions de conteneurs ophtalmiques cor\u00e9ens par ann\u00e9e de travail cor\u00e9en \u00e0 deux \u00e9quipes.<\/span><\/div>\n<p>&nbsp;<\/p>\n<div style=\"background: #fff; border: 1.5px solid #bae6fd; border-top: 4px solid #0369a1; border-radius: 8px; padding: 18px 20px;\"><span style=\"display: block; font-size: 9px; font-weight: bold; color: #f97316; letter-spacing: 1.5px; text-transform: uppercase; margin-bottom: 8px;\">IBM ophtalmique \u00e0 m\u00e9ga-\u00e9chelle<\/span><br \/>\n<span style=\"display: block; font-size: 15px; font-weight: bold; color: #1e3a8a; margin-bottom: 8px; line-height: 1.3;\">Machine de moulage par injection-soufflage EP-ZQ135<\/span><br \/>\n<span style=\"display: block; font-size: 13px; color: #6b7280; line-height: 1.55;\">1 350 KN \u00b7 30 cavit\u00e9s \u00e0 10 ml ophtalmiques \u00b7 6+N zones de barillet \u00b7 37+37 KW \u00b7 ~83M de conteneurs ophtalmiques cor\u00e9ens par an \u2014 \u00e9chelle de la cha\u00eene d'approvisionnement des h\u00f4pitaux nationaux cor\u00e9ens.<\/span><\/div>\n<p>&nbsp;<\/p>\n<div style=\"background: #fff; border: 1.5px solid #bae6fd; border-top: 4px solid #0369a1; border-radius: 8px; padding: 18px 20px;\"><span style=\"display: block; font-size: 9px; font-weight: bold; color: #f97316; letter-spacing: 1.5px; text-transform: uppercase; margin-bottom: 8px;\">Guide des mat\u00e9riaux<\/span><br \/>\n<span style=\"display: block; font-size: 15px; font-weight: bold; color: #1e3a8a; margin-bottom: 8px; line-height: 1.3;\">Moulage par injection-soufflage de PEHD : Guide complet du processus<\/span><br \/>\n<span style=\"display: block; font-size: 13px; color: #6b7280; line-height: 1.55;\">Guide complet de traitement IBM en PEHD \u2014 s\u00e9lection de la qualit\u00e9 (MI 0,3\u20130,8), r\u00e9glage de la temp\u00e9rature du cylindre, sp\u00e9cification de l'\u00e9paisseur de paroi et s\u00e9lection de la s\u00e9rie ZQ pour l'IBM pharmaceutique et chimique domestique.<\/span><\/div>\n<p>&nbsp;<\/p>\n<\/div>\n<\/section>\n<p>&nbsp;<\/p>\n<footer style=\"text-align: center; padding: 32px 0 24px; border-top: 1px solid #e5e7eb;\">\n<p style=\"font-size: 12px; color: #9ca3af; margin: 0;\">\u00c9diteur : Cxm<\/p>\n<\/footer>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>Ophthalmic IBM \u00b7 Eye Drop Container \u00b7 Korean KFDA \u00b7 Korea Ever-Power HDPE Eye Drop Bottle IBM: Korean Production Guide Korean 10 ml HDPE ophthalmic containers are the highest-volume pharmaceutical IBM format in Korea and one of the most technically demanding: dropper cap engagement precision at \u00b10.05 mm, fill-level transparency at 0.30\u20130.40 mm body wall, [&hellip;]<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[26],"tags":[],"class_list":["post-1044","post","type-post","status-publish","format-standard","hentry","category-application-of-isbm"],"_links":{"self":[{"href":"https:\/\/isbm-blow-molding.com\/fr\/wp-json\/wp\/v2\/posts\/1044","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/isbm-blow-molding.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/isbm-blow-molding.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/isbm-blow-molding.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/isbm-blow-molding.com\/fr\/wp-json\/wp\/v2\/comments?post=1044"}],"version-history":[{"count":1,"href":"https:\/\/isbm-blow-molding.com\/fr\/wp-json\/wp\/v2\/posts\/1044\/revisions"}],"predecessor-version":[{"id":1046,"href":"https:\/\/isbm-blow-molding.com\/fr\/wp-json\/wp\/v2\/posts\/1044\/revisions\/1046"}],"wp:attachment":[{"href":"https:\/\/isbm-blow-molding.com\/fr\/wp-json\/wp\/v2\/media?parent=1044"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/isbm-blow-molding.com\/fr\/wp-json\/wp\/v2\/categories?post=1044"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/isbm-blow-molding.com\/fr\/wp-json\/wp\/v2\/tags?post=1044"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}